CME. Bleeding Risk With SSRIs PART : Cardiovascular and Cerebrovascular Considerations.

Autor:	Robbins-Welty, Gregg A., Tuck, Andrew N., Marchant, Dale, Gleason, Andrew, Key, Richard Garrett, Lubrano di Ciccone, Barbara B., Chopra, Deepti A., Mojtahedzadeh, Mona, Fonseca, Fiona, Lokko Amonoo, Hermioni, DeSimone, Andrea, McFarland, Daniel
Předmět:	HEMORRHAGE risk factors HEMORRHAGE complications MEDICAL quality control ANTIDEPRESSANTS CEREBROVASCULAR disease SEROTONIN uptake inhibitors CARDIOVASCULAR diseases CONTINUING education units ANTICOAGULANTS RISK assessment PLATELET aggregation inhibitors MENTAL illness
Zdroj:	Psychiatric Times; Sep2023, Vol. 40 Issue 9, p35-39, 5p
Abstrakt:	The article discusses bleeding risk with selective serotonin reuptake inhbitors (SSRI) with cardiovascular and cerebrovascular considerations. Topics covered include antidepressant-associated bleeding categorized by complication, heart failure and ventricular assist devices, and thromboembolic disease. Also noted is the influence of other factors on antidepressant-associated bleeding
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu